玻璃体切除术后眼内炎:IRIS登记研究
基于美国眼科学会IRIS登记库的回顾性队列研究,分析2013至2022年玻璃体切除术后眼内炎病例。共1,223,777只眼接受手术,1,275只眼纳入分析,中位诊断时间10天,80.9%仅用玻璃体腔抗生素治疗。总体16.1%需眼球摘除或眼内容物剜出,初始因视网膜脱离手术者长期视力更差且脱离率更高。
要点
- 玻璃体切除术后眼内炎罕见但可致眼球丧失,16.1%需眼球摘除或眼内容物剜出。
- 80.9%仅用玻璃体腔抗生素治疗,与再次玻璃体切除组长期视力及眼压无显著差异。
- 初始因视网膜脱离行玻璃体切除者,眼内炎后长期视力更差且视网膜脱离率更高。
核心结论
- 玻璃体切除术后眼内炎虽罕见,但可导致显著并发症甚至眼球丧失。
- 玻璃体腔穿刺注药与再次玻璃体切除两组间长期视力、眼压、杯盘比及眼球摘除率无显著差异。
研究设计与样本
- 回顾性队列研究,数据来自美国眼科学会IRIS登记库。
- 纳入2013至2022年玻璃体切除术后发生眼内炎的患眼,共1,223,777只眼接受手术,1,275只眼符合纳入标准。
主要发现
- 从玻璃体切除至眼内炎诊断的中位时间为10天。
- 80.9%的患眼仅接受玻璃体腔抗生素治疗,未行再次玻璃体切除。
- 总体16.1%的患眼需眼球摘除或眼内容物剜出。
- 初始因视网膜脱离修复行玻璃体切除的患眼,眼内炎后长期视力更差且视网膜脱离发生率更高。
关键数值与推荐
- 长期视力、眼压、杯盘比及眼球摘除或眼内容物剜出率在玻璃体腔穿刺注药与再次玻璃体切除组间无显著差异。
临床怎么用
- 玻璃体切除术后眼内炎多可先采用玻璃体腔抗生素治疗,多数患眼无需再次玻璃体切除。
- 对初始因视网膜脱离手术者,需警惕眼内炎后视力预后较差及视网膜脱离风险。
局限性
- 回顾性登记研究设计,可能存在数据记录偏倚与混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study is to characterize the clinical features, management strategies, and outcomes of endophthalmitis cases following pars plana vitrectomy using data from the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight). METHODS: This is a retrospective cohort study of eyes that developed endophthalmitis following pars plana vitrectomy between 2013 and 2022. Data was collected from the Academy IRIS Registry. This study analyzed differences in visual acuity, intraocular pressure, rates of evisceration and enucleation, and rates of rhegmatogenous retinal detachment following endophthalmitis diagnosis. RESULTS: A total of 1,223,777 unique eyes underwent a PPV during the study period, with 1,275 eyes meeting the inclusion criteria. The median time from pars plana vitrectomy to endophthalmitis diagnosis was 10 days. The majority of eyes (80.9%) were managed with intravitreal antibiotics alone, without a repeat pars plana vitrectomy. Long-term visual acuity, intraocular pressure, cup-to-disc ratio, and rate of evisceration or enucleation did not differ significantly between treatment groups. However, eyes that underwent the initial pars plana vitrectomy for retinal detachment repair had poorer long-term vision and higher rates of retinal detachment following endophthalmitis. Overall, 16.1% of eyes required evisceration or enucleation in this cohort. CONCLUSIONS: Despite its rarity, post-pars plana vitrectomy endophthalmitis can cause significant morbidity and even globe loss. There were no significant differences observed between eyes that were treated with intravitreal tap and inject versus repeat pars plana vitrectomy.
引用
- Hassoun MR, Wang KY, Kim BM, et al. Endophthalmitis Following Pars Plana Vitrectomy: An IRIS® Registry Study. Retina. 2026. PMID: 42765869. doi:10.1097/IAE.0000000000005015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。